This cluster is too small relative to market cap to warrant a bearish read. Monitor for any upcoming 8-K or earnings release that could have motivated the sales, but the dollar amounts suggest diversification or tax planning, not informed selling.
CORT drugs
CORT drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 31 $113.35entry
- T+1 · 3mo ago +0.03%α +0.71% · $113.38
- T+5 · 2mo ago +0.56%α +0.70% · $113.98
- T+20 · 7w ago +1.23%α +1.60% · $114.74
- T+54 · todayOpen
- T+60 · in 7d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Corcept Therapeutics insiders sold a combined $4.01M in stock over a week, including a Director's $3.27M sale. The total value represents ~0.034% of the $11.9B market cap, which is well below the 0.1% materiality threshold, making this a routine liquidity-driven cluster. No C-suite executives participated, and the sales lack the proportionality to signal bearish conviction.
Key Financial Metrics
Key Facts
- Director Park Kimberly sold 26.7K shares for $3.27M on 2026-08-26
- Officer Maduck Sean sold 5.9K shares for $740K on 2026-08-25
- Total cluster value of $4.01M is only ~0.034% of CORT's $11.9B market cap
- No CEO, CFO, or other C-suite executives participated in the cluster
- Two additional non-cash transactions (grant/award and tax withholding) by a separate officer occurred on 2026-09-01, but are $0 economic events
Financial Impact
Total insider sales of $4.01M represent ~0.034% of market cap, trivial and routine
Risk Factors
- Insider sales could accelerate if the stock continues its recent upward trajectory
- No C-suite participation reduces the informational value of this cluster
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1788483682832 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers